drugset / Trial / NCT01263119
A Study of LY2216684 and Warfarin in Healthy Subjects
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine how warfarin might affect LY2216684 and how giving LY2216684 might affect warfarin in the body. Information about any side effects that may occur will also be collected.
Timeline
- Start
- 2010-12
- Primary completion
- 2011-02
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Warfarin | Small molecule | 10 mg | Oral |
| Subject | edivoxetine | Small molecule | 18 mg | Oral |